Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Biological Products / therapeutic use
  • Colitis, Ulcerative / drug therapy*
  • Colon, Descending
  • Colon, Sigmoid
  • Consensus
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Maintenance Chemotherapy
  • Mesalamine / administration & dosage
  • Mesalamine / therapeutic use*
  • Proctitis / drug therapy
  • Remission Induction
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biological Products
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Mesalamine